Put companies on watchlist
CompuGroup Medical SE & Co. KGaA
ISIN: DE000A288904
WKN: A28890
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

CompuGroup Medical SE & Co. KGaA · ISIN: DE000A288904 · EQS - Company News (90 News)
Country: Germany · Primary market: Germany · EQS NID: 1497431
25 November 2022 10:15AM

​​​​​​​CompuGroup Medical plans cooperation with SAP in the hospital sector


EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Alliance
​​​​​​​CompuGroup Medical plans cooperation with SAP in the hospital sector

25.11.2022 / 10:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


Koblenz. CompuGroup Medical (CGM), one of the world’s leading e-health providers, plans a future cooperation with SAP, one of the world's leading providers of software for managing business processes, in the hospital sector. By combining the expertise of both companies, new intelligent solutions are to be created that are specifically tailored to the requirements of the inpatient sector, in order to support the hybrid modular system landscapes of our customers in the best possible and future-proof manner.

SAP and CGM have signed a letter of intent regarding a planned cooperation in the areas of solution integration and go-to-market today, against the background of SAP's decision to offer a standardized platform based on the Fast Health Interoperability (FHIR) standard for connecting hospital information systems.

As part of the planned collaboration and in addition to CGM CLINICAL, CGM will also develop the Revenue Cycle Management (RCM) to cover all administrative and clinical processes in hospitals in the future. RCM refers to the billing and financial process used by hospitals to track the different phases of patient care. SAP will contribute its expertise to the development of this new solution.

Together, the partners will ensure deep process integration of the RCM into the SAP ERP world (e.g. Finance, Accounting, HR) based on the FHIR standard. Both, a cloud and on-premise solution will be offered.

"I am very much looking forward to the collaboration with SAP - after all, two leading German software companies are finally coming together to powerfully advance the digitization so urgently needed in the healthcare sector with innovative solutions. With this partnership, we will offer a long-term end-to-end solution for our customers, both from a technological and process perspective" comments Hannes Reichl, Managing Director Inpatient and Social Care at CGM, on the planned collaboration.

"It needs strong partners with domain know-how along the value chain to develop added values for a digital transformation. With CGM, we have found an experienced partner in healthcare. Complemented by CGM's products, we can offer comprehensive healthcare solutions that are technologically leading while supporting clinical, administrative, and financial processes. This enables us to offer our customers long-term continuity and added value at the same time." Jan Gilg, President and Chief Product Officer SAP S/4 Hana, elaborates.

 

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.025 billion in 2021, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

 



25.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1497431

 
End of News EQS News Service

1497431  25.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1497431&application_name=news&site_id=boersengefluester_html
Visual performance / price development - CompuGroup Medical SE & Co. KGaA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.